Egis Technology : Announcement for the company's board of directors approved the investment in the common shares issued by Precise Biometrics AB in its cash capital increment

Close

Today's Information

Provided by: Egis Technology Inc.
SEQ_NO	6	Date of announcement	2022/08/10	Time of announcement	23:32:13
Subject	Announcement for the company's board of directors approved the investment in the common shares issued by Precise Biometrics AB in its cash capital increment
Date of events	2022/08/10	To which item it meets	paragraph 20
Statement	1.Name and nature of the underlying assets (if preferred shares, the terms and conditions of issuance shall also be indicated, e.g., dividend yield, etc.): Precise Biometrics AB 2.Date of occurrence of the event:2022/08/10 3.Volume, unit price, and total monetary amount of the transaction: Volume of the transaction: The expected transaction volume is calculated based on around 12% of the capital of Precise Biometrics AB after its cash capital increment. Unit price of the transaction: SEK6.44 Total monetary amount of the transaction: approximately NT$ 110,000 thousand~ NT$ 130,000 thousand. 4.Trading counterparty and its relationship to the Company (if the trading counterparty is a natural person and furthermore is not a related party of the Company, the name of the trading counterparty is not required to be disclosed): non-related party 5.Where the trading counterparty is a related party, announcement shall also be made of the reason for choosing the related party as trading counterparty and the identity of the previous owner, its relationship with the Company and the trading counterparty, and the previous date and monetary value of transfer: Not applicable 6.Where an owner of the underlying assets within the past five years has been an related party of the Company, the announcement shall also include the date and price of acquisition and disposal by the related party, and its relationship to the Company at the time of the transaction:Not applicable 7.Matters related to the current disposal of creditors' rights (including types of collaterals of the disposed creditor's rights; if creditor's rights over a related party, announcement shall be made of the name of the related party and the book amount of the creditor's rights, currently being disposed of, over such related party: Not applicable 8.Profit or loss from the disposal (not applicable in cases of acquisition of securities) (where originally deferred, the status of recognition shall be listed and explained): Not applicable 9.Terms of delivery or payment (including payment period and monetary value), restrictive covenants in the contract, and other important terms and conditions: Terms of delivery or payment: according to the payment notice 10.The manner in which the current transaction was decided, the reference basis for the decision on price, and the decision-making unit: Decision method: approved by the audit committee and the board of directors The reference basis for the decision on price: in accordance with the price reasonableness assessment opinion issued by the accountant The decision-making unit: the audit committee and the board of directors of the company. 11.Net worth per share of the Company's underlying securities acquired or disposed of: Not applicable 12.Cumulative no.of shares held (including the current transaction), their monetary value, shareholding percentage, and status of any restriction of rights (e.g., pledges), as of the present moment: (1)Volume: The expected transaction volume is calculated based on around 12% of the capital of Precise Biometrics AB after its cash capital increment. (2)Transaction amount:approximately NT$110,000thousand~NT$130,000thousand (3)Shareholding percentage: around 12% (4)Restriction of rights: none 13.Ratio of securities investment (including the current transaction) to the total assets and shareholder's equity of the parent company on the latest financial statements, and the operating capital on the latest financial statements, as of the present moment: (1)Proportion of total assets of ：68.13% (2)Proportion of equity attributable to owners of parent company：126.64% (3)Working capital amount：NT$ 3,408,921 thousand 14.Broker and broker's fee: Not applicable 15.Concrete purpose or use of the acquisition or disposal: In order to diversify product applications tapping into new fields such as AIoT. 16.Whether the directors expressed any objection to the current transaction: None 17.Whether the counterparty of the current transaction is a related party: None 18.Date of the Board of Directors' resolution: NA 19.Date of ratification by supervisors or approval by the Audit Committee: NA 20.Whether the CPA issued an opinion on the unreasonableness regarding the current transaction: None 21.Name of the CPA firm: SmartCPA Inc. 22.Name of the CPA: Cyong-Hua, Ruan, CPA 23.License no.of the CPA:No. 2719; Cyong-Hua, Ruan, CPA 24.Any other matters that need to be specified: The actual volume of shares purchased shall be announced after delivered.